Assignee
COURIER THERAPEUTICS INC
US·0 granted patents·2 pending applications·0 citations·filing 2020–2020
Top patents by PatentIndex Score
2 records- 0149US2023002450A1Bispecific Fusion Protein Using Orthopoxvirus Major Histocompatibility Complex (MHC) Class I-Like Protein (OMCP) and Tumor-Specific Binding PartnerCOURIER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0241US2022323541A1Orthopoxvirus major histocompatibility complex (mhc) class-i like protein (omcp) for treatment of autoimmune diseaseCOURIER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COURIER THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →